secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001493152-24-009438
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAffinity closes $2.5M direct offering of 1.6M shares and 1.6M warrants at $1.5625/unit
--------------------------------------------------------------------------------

- Offering includes 1.6M shares (registered direct) and 1.6M common warrants (private placement) at combined $1.5625/share.
- Warrants exercisable at $1.64 per share, subject to shareholder approval, expiring five years after approval date.
- Gross proceeds ~$2.5M; net proceeds for working capital and general corporate purposes.
- IPO warrant exercise price reduced to $3.0625 upon issuance of new shares and warrants.
- WallachBeth Capital acted as sole placement agent; closing occurred March 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315224009438/0001493152-24-009438-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315224009438/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009438

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer